title: Myeloablative conditioning in myelofibrosis using i.v. treosulfan and autologous peripheral blood progenitor cell transplantation with high doses of CD34+ cells results in hematologic responses. A follow-up of three patients.
authors.affiliation: Department of Internal Medicine V, University of Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany; stefan_fruehauf@med.uni-heidelberg.de
authors.forename: Stefan
authors.initials: S
authors.lastname: Fruehauf
authors.forename: Eike C
authors.initials: EC
authors.lastname: Buss
authors.forename: Julian
authors.initials: J
authors.lastname: Tropaly
authors.forename: H H
authors.initials: HH
authors.lastname: Kreipe
authors.forename: A D
authors.initials: AD
authors.lastname: Ho
mesh_terms: D018952:Antigens, CD34 / Q000097:blood; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D002066:Busulfan / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D036102:Peripheral Blood Stem Cell Transplantation; D055728:Primary Myelofibrosis / Q000628:therapy*; D019172:Transplantation Conditioning / Q000379:methods*; D014182:Transplantation, Autologous
chemical_list: D018952:Antigens, CD34; D018906:Antineoplastic Agents, Alkylating; C018404:treosulfan; D002066:Busulfan